BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16740526)

  • 1. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.
    Altarescu G; Brooks B; Kaplan Y; Eldar-Geva T; Margalioth EJ; Levy-Lahad E; Renbaum P
    Hum Reprod; 2006 Aug; 21(8):2047-51. PubMed ID: 16740526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations.
    Altarescu G; Eldar-Geva T; Varshower I; Brooks B; Haran EZ; Margalioth EJ; Levy-Lahad E; Renbaum P
    Hum Reprod; 2009 Dec; 24(12):3225-9. PubMed ID: 19687056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preimplantation genetic diagnosis for neurofibromatosis type 1.
    Spits C; De Rycke M; Van Ranst N; Joris H; Verpoest W; Lissens W; Devroey P; Van Steirteghem A; Liebaers I; Sermon K
    Mol Hum Reprod; 2005 May; 11(5):381-7. PubMed ID: 15833774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polar body-based preimplantation genetic diagnosis for N-acetylglutamate synthase deficiency.
    Altarescu G; Brooks B; Eldar-Geva T; Margalioth EJ; Singer A; Levy-Lahad E; Renbaum P
    Fetal Diagn Ther; 2008; 24(3):170-6. PubMed ID: 18753752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First systematic experience of preimplantation genetic diagnosis for de-novo mutations.
    Rechitsky S; Pomerantseva E; Pakhalchuk T; Pauling D; Verlinsky O; Kuliev A
    Reprod Biomed Online; 2011 Apr; 22(4):350-61. PubMed ID: 21324748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.
    Lázaro C; Ravella A; Gaona A; Volpini V; Estivill X
    N Engl J Med; 1994 Nov; 331(21):1403-7. PubMed ID: 7969279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
    Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
    Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolving a genetic paradox throughout preimplantation genetic diagnosis for autosomal dominant severe congenital neutropenia.
    Malcov M; Reches A; Ben-Yosef D; Cohen T; Amit A; Dgany O; Tamary H; Yaron Y
    Prenat Diagn; 2010 Mar; 30(3):207-11. PubMed ID: 20049848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers.
    Oğuzkan S; Cinbiş M; Ayter S; Anlar B; Aysun S
    Turk J Pediatr; 2003; 45(3):192-7. PubMed ID: 14696795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex PCR combining deltaF508 mutation and intragenic microsatellites of the CFTR gene for pre-implantation genetic diagnosis (PGD) of cystic fibrosis.
    Moutou C; Gardes N; Viville S
    Eur J Hum Genet; 2002 Apr; 10(4):231-8. PubMed ID: 12032730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1.
    Upadhyaya M; Majounie E; Thompson P; Han S; Consoli C; Krawczak M; Cordeiro I; Cooper DN
    Hum Genet; 2003 Jan; 112(1):12-7. PubMed ID: 12483293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfecta.
    Chen L; Diao Z; Xu Z; Zhou J; Yan G; Sun H
    Syst Biol Reprod Med; 2019 Feb; 65(1):75-80. PubMed ID: 29764212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGD on a recombinant allele: crossover between the TSC2 gene and 'linked' markers impairs accurate diagnosis.
    Altarescu G; Eldar Geva T; Brooks B; Margalioth E; Levy-Lahad E; Renbaum P
    Prenat Diagn; 2008 Oct; 28(10):929-33. PubMed ID: 18792920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
    Rübben A; Bausch B; Nikkels A
    Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGD for germline mosaicism.
    Altarescu G; Beeri R; Eldar-Geva T; Varshaver I; Margalioth EJ; Levy-Lahad E; Renbaum P
    Reprod Biomed Online; 2012 Oct; 25(4):390-5. PubMed ID: 22884613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.